跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
tPA-2
首页
药物
tPA-2
tPA-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for large scale production of recombinant DNA-derived TPA or K2S molecules
US 6955910 B2
申请人: BOEHRINGER INGELHEIM INT
优先权: 2001
US
4 件公开
RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (TPA) FRAGMENTS AND USES THEREOF
EP 4713445 A2
申请人: VERSITI BLOOD RES INSTITUTE FOUNDATION INC
优先权: 2023
CN
EP
WO
3 件公开
Tissue plasminogen activator antibodies and methods of use
US 10160813 B2
申请人: UNIV TENNESSEE RES FOUND
优先权: 2014
CN
US
3 件公开
Therapeutic compositions and methods for treating diseases that involve angiogenesis
US 2005277575 A1
申请人: SEMOV ALEXANDRE
优先权: 2004
US
WO
2 件公开
Compound inhibiting activation of the enzyme Erk 1/2 to be used in the treatment of neurodegenerative illnesses
US 9000047 B2
申请人: NAVARRO MEDRANO PILAR
优先权: 2010
US
2 件公开
Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
US 6692931 B1
申请人: REUTTER WERNER
优先权: 1998
US
METHOD AND COMPOSITION FOR TREATMENT OF ISCHEMIC NEURONAL REPERFUSION INJURY
WO 0141756 A8
申请人: UNIV SOUTH FLORIDA
优先权: 1999
WO
Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules
CN 1541271 A
申请人: BOEHRINGER INGELHEIM INT
优先权: 2000
CN
Modulation of cell growth
US 2004071707 A1
申请人: CARROLL VERONICA A
优先权: 2000
US
Peptides having affinity for the GP 120 viral protein and use thereof
CN 1487951 A
申请人: COMMISSARIAT ENERGIE ATOMIQUE
优先权: 2001
CN
第 1 / 6 页
上一页
下一页
药物
反馈